Bexarotene Topical
75 interactions 92 cited referencesTopical bexarotene is used to treat cutaneous T-cell lymphoma (CTCL, a type of skin cancer) that could not be treated with other medications. Bexarotene is in a class of medications called retinoids. It works by stopping the growth of cancer cells. Read the full Bexarotene Topical drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Bexarotene Topical Adenovirus Vaccine Type 4, Live An increased risk of infection by the live vaccine Details Bexarotene Topical Adenovirus Vaccine Type 7, Live An increased risk of infection by the live vaccine Details Bexarotene Topical Alfentanil Reduced ALfentanil exposure, reduced efficacy of ALfentanil and an increased risk of a withdrawal syndrome Details Bexarotene Topical Amlodipine Amvaz® Reduced amLODIPine exposure Details Bexarotene Topical Atogepant Qulipta Reduced atogepant exposure Details Bexarotene Topical Azathioprine Azasan An increased risk of hepatotoxicity Details Bexarotene Topical Cariprazine Vraylar Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Bexarotene Topical Chlortetracycline An increased risk of pseudotumor cerebri (benign intracranial hypertension) Details Bexarotene Topical Cholera Vaccine Ipol An increased risk of infection by the live vaccine Details Bexarotene Topical Demeclocycline Declomycin® An increased risk of pseudotumor cerebri (benign intracranial hypertension) Details Bexarotene Topical Desogestrel Decreased contraceptive effectiveness Details Bexarotene Topical Dienogest Decreased contraceptive effectiveness Details Bexarotene Topical Doxycycline Acticlate An increased risk of pseudotumor cerebri (benign intracranial hypertension) Details Bexarotene Topical Drospirenone Decreased contraceptive effectiveness Details Bexarotene Topical Ebola Zaire Vaccine, Live An increased risk of infection by the live vaccine Details Bexarotene Topical Efavirenz Reduced efavirenz exposure with reduced efficacy; reduced bexarotene exposure with reduced efficacy Details Bexarotene Topical Eravacycline Xerava An increased risk of pseudotumor cerebri (benign intracranial hypertension) Details Bexarotene Topical Estradiol Delestrogen Decreased contraceptive effectiveness Details Bexarotene Topical Ethinyl Estradiol Decreased contraceptive effectiveness Details Bexarotene Topical Ethynodiol Decreased contraceptive effectiveness Details Bexarotene Topical Etonogestrel Nexplanon Decreased contraceptive effectiveness Details Bexarotene Topical Gemfibrozil Lopid Increased plasma concentrations of bexarotene Details Bexarotene Topical Gestodene Decreased contraceptive effectiveness Details Bexarotene Topical Influenza Virus Vaccine, Live An increased risk of infection by the live vaccine Details Bexarotene Topical Levoketoconazole Recorlev Increased risk of serious hepatotoxicity and drug-induced liver injury Details Bexarotene Topical Levonorgestrel After banger Decreased contraceptive effectiveness Details Bexarotene Topical Lumateperone Caplyta Reduced lumateperone exposure Details Bexarotene Topical Lymecycline An increased risk of pseudotumor cerebri (benign intracranial hypertension) Details Bexarotene Topical Meclocycline An increased risk of pseudotumor cerebri (benign intracranial hypertension) Details Bexarotene Topical Medroxyprogesterone Amen® Decreased contraceptive effectiveness Details Bexarotene Topical Mercaptopurine Purinethol® An increased risk of hepatotoxicity Details Bexarotene Topical Mestranol Decreased contraceptive effectiveness Details Bexarotene Topical Methacycline An increased risk of pseudotumor cerebri (benign intracranial hypertension) Details Bexarotene Topical Methotrexate Jylamvo An increased risk of hepatotoxicity, an increased methotrexate exposure, an increased risk of methotrexate-related severe adverse... Details Bexarotene Topical Minocycline Amzeeq An increased risk of pseudotumor cerebri (benign intracranial hypertension) Details Bexarotene Topical Nifedipine Adalat® Reduced NIFEdipine exposure Details Bexarotene Topical Nomegestrol Decreased contraceptive effectiveness Details Bexarotene Topical Norelgestromin Decreased contraceptive effectiveness Details Bexarotene Topical Norethindrone Aygestin Decreased contraceptive effectiveness Details Bexarotene Topical Norgestimate Decreased contraceptive effectiveness DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist